Impact of a care package on preventing delirium in CABG patients
Determining the Effect of Care Package Implementation in Preventing Delirium in Patients Undergoing Coronary Artery Bypass Graft Surgery
This study tests if a special care package can help prevent confusion after heart surgery in patients getting coronary artery bypass graft (CABG) surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 128 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Kilis 7 Aralik University Academic / other |
| Locations | 1 site (Kilis) |
| Trial ID | NCT06036017 on ClinicalTrials.gov |
What this trial studies
This research investigates the effectiveness of a care package designed to prevent postoperative delirium in patients undergoing coronary artery bypass graft (CABG) surgery. The care package includes strategies such as optimal pain management, sleep regulation, mobilization, patient orientation, and appropriate medication management. By implementing these practices, the study aims to reduce the incidence of delirium, which can complicate recovery and increase healthcare costs. The results will help determine the effectiveness of this approach in improving patient outcomes following CABG surgery.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old undergoing their first CABG surgery with low-risk ASA classifications.
Not a fit: Patients with psychiatric diagnoses or those requiring corticosteroid medications may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of delirium in CABG patients, leading to better recovery and lower healthcare costs.
How similar studies have performed: Other studies have shown promising results with similar care bundle approaches in reducing postoperative complications, suggesting potential success for this intervention.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Participants and Sample Criteria Inclusion criteria for the study: * Over 18 years of age, * Considered as a low-risk group according to American Society of Anesthesiologists (ASA) * I-II and EUROSCORE scores * Undergoing open-heart surgery for the first time * Having an operation with on-pump and median sternotomy technique, * Mild and moderate hypothermia applied, * One to three coronary artery bypass grafts performed, * Left internal mammary artery and saphenous vein graft applied, * Surgery initiated between 08:00-12:00 hours, * Having no psychiatric diagnosis and therefore no drug therapy, * Not using corticosteroid derivative drugs, * No complications observed that may affect the surgery and ICU process, * Having a family member who can support the patient in the postoperative wake-up process, * Patients who voluntarily agree to participate in the research will be included. Exclusion Criteria: * Extended surgery due to complications, * Completion of the intraoperative process falls into the evening hours (after 16:00), * Consciousness level after extubation prevents participation in the study (Glasgow Coma Score \<15), * Corticosteroid derivative drugs applied at any stage of the perioperative process, Surgery is canceled, * No family member is available to stay in the intensive care unit, * Wishing to withdraw from the research at any stage after voluntarily agreeing to participate in the study, * At any stage of the research, patients who do not wish to use earplugs or listen to music and wish to withdraw from the research, their data will be excluded from the study.
Where this trial is running
Kilis
- Islam — Kilis, Turkey (Recruiting)
Study contacts
- Study coordinator: İslam Elagoz, Ress. ass.
- Email: islam.elagoz@kilis.edu.tr
- Phone: 05072836124
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.